Replies to post #114960 on Biotech Values

[DewDiligence]

You’re correct; although CYTR’s buyout of Innovive did not have a separately- traded CVR, it did have an earnout feature. This is the 2008 PR announcing the deal:

http://www.businesswire.com/portal/site/google/?ndmViewId=news_view&newsId=20080609005549&newsLang=en

What’s notable about this deal is that the earnout was almost the entire value of what Innovive’s shareholders received in the deal.